Sort by
Refine Your Search
-
to ample opportunities in developing an academic career. The appointment will commence as soon as possible on a temporary basis for 1 to 3 year(s), with the possibility of renewal subject to satisfactory
-
technical skills in next generation sequencing, including library preparation and bioinformatics analysis. Experience in developing bioinformatics pipeline and maintaining computer server would be
-
Bioengineering or Biomedical Engineering, with good experience in biological imaging and image processing. Those with basic knowledge of imaging system development would have an advantage. The appointee should be
-
advanced expertise in developing AI applications using offline/online LLMs (e.g., GPT, Qwen, DeepSeek, Mistral, Llama, Gemma) within Linux environments. They must also demonstrate proficiency in clinical
-
Post-doctoral Fellow Scheme. The appointee is expected to contribute to the research project “Justice in China: Showing the way with forensic voice comparison” and develop their own project(s) in
-
caregivers of older adults and/or geron-technology and AI, and will be responsible for engaging in managing and executing projects, writing funding proposals, developing publications, and as well as engaging
-
of literature and focus-group interviews in schools admitting multicultural students at pre-primary and primary levels. They will be responsible for developing study designs, overseeing the timeline of project
-
intellectually to research development are requisites for the position. The appointee will investigate the molecular mechanism of liver cancer using next generation sequencing. Enquiries about the duties
-
software package (e.g. SPSS, Stata, SAS, R, Mplus) is required. The appointee will join an internationally active team of researchers in developing studies in the area of digital phenotyping in early
-
the Department of Microbiology. Applicants should have a Ph.D. degree with extensive research experience in virology or biochemistry; expertise in virus-host proteome and antiviral drug development will be